GATA4 Lentivirus, 2×200µl
To Order Contact us: bjorn@lembcke.dk
GATA4 Antibody |
|||
AF6316 | Affbiotech | 200ul | EUR 420 |
GATA4 Antibody |
|||
AF6317 | Affbiotech | 200ul | EUR 420 |
GATA4 siRNA |
|||
20-abx917618 | Abbexa |
|
|
GATA4 siRNA |
|||
20-abx917619 | Abbexa |
|
|
GATA4 Antibody |
|||
CSB-PA546814-100ul | Cusabio | 100ul | EUR 379.2 |
Description: A polyclonal antibody against GATA4. Recognizes GATA4 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
GATA4 antibody |
|||
70R-49781 | Fitzgerald | 100 ul | EUR 292.8 |
Description: Purified Polyclonal GATA4 antibody |
GATA4 antibody |
|||
70R-21541 | Fitzgerald | 50 ul | EUR 522 |
Description: Rabbit polyclonal GATA4 antibody |
GATA4 antibody |
|||
70R-31721 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal GATA4 antibody |
GATA4 antibody |
|||
70R-33601 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal GATA4 antibody |
GATA4 antibody |
|||
70R-33603 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal GATA4 antibody |
GATA4 antibody |
|||
70R-51546 | Fitzgerald | 100 ul | EUR 292.8 |
Description: Purified Polyclonal GATA4 antibody |
GATA4 Antibody |
|||
48130-100ul | SAB | 100ul | EUR 399.6 |
GATA4 Antibody |
|||
48130-50ul | SAB | 50ul | EUR 286.8 |
GATA4 Antibody |
|||
49544-100ul | SAB | 100ul | EUR 399.6 |
GATA4 Antibody |
|||
49544-50ul | SAB | 50ul | EUR 286.8 |
GATA4 antibody |
|||
20R-2714 | Fitzgerald | 50 ug | EUR 337.2 |
Description: Rabbit polyclonal GATA4 antibody |
GATA4 Antibody |
|||
33773-100ul | SAB | 100ul | EUR 302.4 |
GATA4 Antibody |
|||
33773-50ul | SAB | 50ul | EUR 224.4 |
Gata4 antibody |
|||
10R-6702 | Fitzgerald | 100 ug | EUR 502.8 |
Description: Rat monoclonal Gata4 antibody |
GATA4 antibody |
|||
10R-1812 | Fitzgerald | 100 ul | EUR 522 |
Description: Mouse monoclonal GATA4 antibody |
GATA4 antibody |
|||
10R-4165 | Fitzgerald | 100 ul | EUR 829.2 |
Description: Mouse monoclonal GATA4 antibody |
GATA4 antibody |
|||
10R-4166 | Fitzgerald | 100 ul | EUR 871.2 |
Description: Mouse monoclonal GATA4 antibody |
GATA4 Antibody |
|||
ABF5245 | Lifescience Market | 100 ug | EUR 525.6 |
GATA4 Antibody |
|||
ABF6316 | Lifescience Market | 100 ug | EUR 525.6 |
GATA4 Antibody |
|||
ABF6317 | Lifescience Market | 100 ug | EUR 525.6 |
GATA4 siRNA |
|||
20-abx902099 | Abbexa |
|
|
GATA4 Antibody |
|||
CSB-PA084937- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against GATA4. Recognizes GATA4 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
GATA4 Antibody |
|||
F53689-0.1ML | NSJ Bioreagents | 0.1 ml | EUR 379 |
GATA4 Antibody |
|||
F43474-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
GATA4 Antibody |
|||
F43474-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
GATA4 Antibody |
|||
CSB-PA546814- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against GATA4. Recognizes GATA4 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
GATA4 Conjugated Antibody |
|||
C49544 | SAB | 100ul | EUR 476.4 |
GATA4 Blocking Peptide |
|||
AF5245-BP | Affbiotech | 1mg | EUR 234 |
GATA4 Blocking Peptide |
|||
AF6316-BP | Affbiotech | 1mg | EUR 234 |
GATA4 Blocking Peptide |
|||
AF6317-BP | Affbiotech | 1mg | EUR 234 |
GATA4 antibody (Ser262) |
|||
70R-33600 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal GATA4 antibody (Ser262) |
GATA4 antibody (Ser105) |
|||
70R-33602 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal GATA4 antibody (Ser105) |
GATA4 Rabbit pAb |
|||
A13756-100ul | Abclonal | 100 ul | EUR 369.6 |
GATA4 Rabbit pAb |
|||
A13756-200ul | Abclonal | 200 ul | EUR 550.8 |
GATA4 Rabbit pAb |
|||
A13756-20ul | Abclonal | 20 ul | EUR 219.6 |
GATA4 Rabbit pAb |
|||
A13756-50ul | Abclonal | 50 ul | EUR 267.6 |
GATA4 (pS262) Antibody |
|||
abx012008-100ug | Abbexa | 100 ug | EUR 526.8 |
GATA4 (pS105) Antibody |
|||
abx012009-100ug | Abbexa | 100 ug | EUR 526.8 |
GATA4 Blocking Peptide |
|||
20-abx062121 | Abbexa |
|
|
GATA4 Blocking Peptide |
|||
20-abx062656 | Abbexa |
|
|
GATA4 Mouse mAb |
|||
A3600-100ul | Abclonal | 100 ul | EUR 369.6 |
GATA4 Mouse mAb |
|||
A3600-200ul | Abclonal | 200 ul | EUR 550.8 |
GATA4 Mouse mAb |
|||
A3600-20ul | Abclonal | 20 ul | Ask for price |
GATA4 Mouse mAb |
|||
A3600-50ul | Abclonal | 50 ul | EUR 267.6 |
GATA4-Specific Antibody |
|||
abx233363-100ug | Abbexa | 100 ug | EUR 577.2 |
GATA4 (pS105) Antibody |
|||
abx333334-100ul | Abbexa | 100 ul | EUR 560.4 |
GATA4 (pS262) Antibody |
|||
abx333361-100ul | Abbexa | 100 ul | EUR 560.4 |
Anti-GATA4 Antibody |
|||
A00499-1 | BosterBio | 100ug/vial | EUR 352.8 |
Recombinant mouse GATA4 |
|||
P2044 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for mouse GATA4 |
anti-GATA4 (6H10) |
|||
LF-MA30301 | Abfrontier | 100 ul | EUR 644.4 |
Description: Mouse Monoclonal to GATA4 |
Anti-GATA4 antibody |
|||
STJ23755 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a member of the GATA family of zinc-finger transcription factors. Members of this family recognize the GATA motif which is present in the promoters of many genes. This protein is thought to regulate genes involved in embryogenesis and in myocardial differentiation and function, and is necessary for normal testicular development. Mutations in this gene have been associated with cardiac septal defects. Additionally, alterations in gene expression have been associated with several cancer types. Alternative splicing results in multiple transcript variants. |
Anti-GATA4 antibody |
|||
STJ115704 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a member of the GATA family of zinc-finger transcription factors. Members of this family recognize the GATA motif which is present in the promoters of many genes. This protein is thought to regulate genes involved in embryogenesis and in myocardial differentiation and function, and is necessary for normal testicular development. Mutations in this gene have been associated with cardiac septal defects. Additionally, alterations in gene expression have been associated with several cancer types. Alternative splicing results in multiple transcript variants. |
Phospho-GATA4 (Ser262) Antibody |
|||
CSB-PA207170-100ul | Cusabio | 100ul | EUR 434.4 |
Description: A polyclonal antibody against Phospho-GATA4 (Ser262). Recognizes Phospho-GATA4 (Ser262) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
Phospho-GATA4 (S262) Antibody |
|||
1-CSB-PA008720 | Cusabio |
|
|
Description: A polyclonal antibody against Phospho-GATA4 (S262). Recognizes Phospho-GATA4 (S262) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IF, ELISA;WB:1/500-1/2000.IF:1/200-1/1000.ELISA:1/5000 |
Phospho-GATA4 (S105) Antibody |
|||
1-CSB-PA008722 | Cusabio |
|
|
Description: A polyclonal antibody against Phospho-GATA4 (S105). Recognizes Phospho-GATA4 (S105) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, IF, ELISA;IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/20000 |
Rat GATA4 shRNA Plasmid |
|||
20-abx985798 | Abbexa |
|
|
Phospho-GATA4 (Ser262) Antibody |
|||
AF3316 | Affbiotech | 200ul | EUR 420 |
Phospho-GATA4 (Ser105) Antibody |
|||
AF3317 | Affbiotech | 200ul | EUR 420 |
Mouse GATA4 shRNA Plasmid |
|||
20-abx970476 | Abbexa |
|
|
Human GATA4 shRNA Plasmid |
|||
20-abx951742 | Abbexa |
|
|
Phospho-GATA4 (Ser105) Antibody |
|||
CSB-PA592497-100ul | Cusabio | 100ul | EUR 434.4 |
Description: A polyclonal antibody against Phospho-GATA4 (Ser105). Recognizes Phospho-GATA4 (Ser105) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
anti- GATA4-Specific antibody |
|||
FNab03363 | FN Test | 100µg | EUR 606.3 |
Description: Antibody raised against GATA4-Specific |
Mouse GATA4 ELISA Kit |
|||
EMG0100 | Abclonal | 96Tests | EUR 625.2 |
Sheep GATA4 ELISA Kit |
|||
ESG0100 | Abclonal | 96Tests | EUR 625.2 |
Human GATA4 ELISA Kit |
|||
EHG0100 | Abclonal | 96Tests | EUR 625.2 |
Monkey GATA4 ELISA Kit |
|||
EMKG0100 | Abclonal | 96Tests | EUR 625.2 |
Rat GATA4 ELISA Kit |
|||
ERG0100 | Abclonal | 96Tests | EUR 625.2 |
Rabbit GATA4 ELISA Kit |
|||
ERTG0100 | Abclonal | 96Tests | EUR 625.2 |
Porcine GATA4 ELISA Kit |
|||
EPG0100 | Abclonal | 96Tests | EUR 625.2 |
GATA4 (Phospho-Ser262) Antibody |
|||
12043-100ul | SAB | 100ul | EUR 302.4 |
GATA4 (Phospho-Ser262) Antibody |
|||
12043-50ul | SAB | 50ul | EUR 224.4 |
GATA4 (Phospho-Ser105) Antibody |
|||
12044-100ul | SAB | 100ul | EUR 302.4 |
GATA4 (Phospho-Ser105) Antibody |
|||
12044-50ul | SAB | 50ul | EUR 224.4 |
Phospho- GATA4 (Ser262) Antibody |
|||
ABF3316 | Lifescience Market | 100 ug | EUR 525.6 |
Phospho- GATA4 (Ser105) Antibody |
|||
ABF3317 | Lifescience Market | 100 ug | EUR 525.6 |
GATA4 Cell ELISA Kit |
|||
abx595250-96tests | Abbexa | 96 tests | EUR 764.4 |
Anti-GATA4 Monoclonal Antibody |
|||
M00499 | BosterBio | 100uL | EUR 531.6 |
Description: Mouse Monoclonal GATA4 Antibody. Validated in WB and tested in Human. |
Goat GATA4 ELISA Kit |
|||
EGTG0100 | Abclonal | 96Tests | EUR 625.2 |
Bovine GATA4 ELISA Kit |
|||
EBG0100 | Abclonal | 96Tests | EUR 625.2 |
Canine GATA4 ELISA Kit |
|||
ECG0100 | Abclonal | 96Tests | EUR 625.2 |
Chicken GATA4 ELISA Kit |
|||
ECKG0100 | Abclonal | 96Tests | EUR 625.2 |
GATA4 ELISA KIT|Human |
|||
EF006852 | Lifescience Market | 96 Tests | EUR 826.8 |
Anserini GATA4 ELISA Kit |
|||
EAG0100 | Abclonal | 96Tests | EUR 625.2 |
Anti-GATA4-Specific antibody |
|||
PAab03363 | Lifescience Market | 100 ug | EUR 426 |
pcDNA3.1- Flag- GATA4 Plasmid |
|||
PVT7197 | Lifescience Market | 2 ug | EUR 319.2 |
pcDNA3.1-Flag-GATA4 Plasmid |
|||
PVTB00101-2a | Lifescience Market | 2 ug | EUR 427.2 |
pCR4-TOPO-GATA4 Plasmid |
|||
PVTB00101S | Lifescience Market | 2 ug | EUR 427.2 |
GATA4 Recombinant Protein (Rat) |
|||
RP202283 | ABM | 100 ug | Ask for price |
GATA4 Recombinant Protein (Human) |
|||
RP060204 | ABM | 100 ug | Ask for price |
GATA4 Recombinant Protein (Mouse) |
|||
RP135983 | ABM | 100 ug | Ask for price |
Phospho-GATA4 (Ser262) Antibody |
|||
CSB-PA207170- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against Phospho-GATA4 (Ser262). Recognizes Phospho-GATA4 (Ser262) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
Phospho-GATA4 (Ser105) Antibody |
|||
CSB-PA592497- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against Phospho-GATA4 (Ser105). Recognizes Phospho-GATA4 (Ser105) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
TMPRSS2 Lentivirus |
|||
78011-1 | BPS Bioscience | 100 µl | EUR 795 |
Description: Human transmembrane serine protease 2 (TMPRSS2) is an enzyme primarily expressed by endothelial cells across the respiratory and digestive tracts. It is involved in viral entry and spread of coronaviruses including SARS-CoV-2, the virus that causes COVID19. TMPRSS2 primes the spike protein by cleaving at the S1/S2 site, leading to the virus fusing to the respiratory epithelia on the cell surface through binding to ACE2. Blocking TMPRSS2 activity could potentially be an effective clinical therapy for COVID-19._x000D_ The TMPRSS2 Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain an TMPRSS2 gene (NM_005656.4) driven by an EF1a promoter._x000D_ |
TMPRSS2 Lentivirus |
|||
78011-2 | BPS Bioscience | 500 µl | EUR 2980 |
Description: Human transmembrane serine protease 2 (TMPRSS2) is an enzyme primarily expressed by endothelial cells across the respiratory and digestive tracts. It is involved in viral entry and spread of coronaviruses including SARS-CoV-2, the virus that causes COVID19. TMPRSS2 primes the spike protein by cleaving at the S1/S2 site, leading to the virus fusing to the respiratory epithelia on the cell surface through binding to ACE2. Blocking TMPRSS2 activity could potentially be an effective clinical therapy for COVID-19._x000D_ The TMPRSS2 Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain an TMPRSS2 gene (NM_005656.4) driven by an EF1a promoter._x000D_ |
TMPRSS2 Lentivirus |
|||
78011-3 | BPS Bioscience | 500 µl x 2 | EUR 3995 |
Description: Human transmembrane serine protease 2 (TMPRSS2) is an enzyme primarily expressed by endothelial cells across the respiratory and digestive tracts. It is involved in viral entry and spread of coronaviruses including SARS-CoV-2, the virus that causes COVID19. TMPRSS2 primes the spike protein by cleaving at the S1/S2 site, leading to the virus fusing to the respiratory epithelia on the cell surface through binding to ACE2. Blocking TMPRSS2 activity could potentially be an effective clinical therapy for COVID-19._x000D_ The TMPRSS2 Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain an TMPRSS2 gene (NM_005656.4) driven by an EF1a promoter._x000D_ |
RFP Lentivirus |
|||
78347-P | BPS Bioscience | 500 µl x 2 | EUR 795 |
Description: TurboRFP is a red (orange) fluorescent protein derived from sea anemone Entacmaea quadricolor. The RFP Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types mammalian cells, including primary and non-dividing cells. These viruses constitutively express TurboRFP under a CMV promoter. RFP expression and transduction efficiency can easily be verified and optimized via fluorescence microscopy or flow cytometry. RFP has an excitation wavelength of 553 nm, an emission wavelength of 574 nm, and an extinction coefficient of 92,000 M-1cm-1. |
CD8a Lentivirus |
|||
78648 | BPS Bioscience | 500 µl x 2 | EUR 995 |
Description: CD8 (cluster of differentiation 8) is a cell surface glycoprotein found on most cytotoxic T lymphocytes that functions within the immune system to mediate cell-cell interactions. The functional forms of CD8 consist of either a heterodimer of two isoforms, CD8α and CD8β, or a homodimer of two CD8α molecules. CD8 acts as a coreceptor to facilitate binding between the T-cell Receptor (TCR) and the class I Major Histocompatibility Complex (MHC). Studying CD8 and its importance in isoimmunity can further our understanding of post-transplant recognition.The CD8a (CD8α, CD8 alpha) Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human CD8a (NM_001768.6) driven by an EF1a promoter and a puromycin selection marker.) |
CD19 Lentivirus |
|||
78657 | BPS Bioscience | 500 µl x 2 | EUR 995 |
Description: The CD19 Lentiviruses are replication incompetent, HIV based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express human CD19 (NM_001770) under the control of an EF1a promoter. |
CD20 Lentivirus |
|||
78658 | BPS Bioscience | 500 µl x 2 | EUR 995 |
Description: The CD20 Lentiviruses are replication incompetent, HIV based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express human CD20 (NM_021950) under the control of an EF1a promot/ . |
CD22 Lentivirus |
|||
78659 | BPS Bioscience | 500 µl x 2 | EUR 995 |
Description: The CD22 Lentiviruses are replication incompetent, HIV based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express human CD22 (NM_001771) under the control of an EF1a promoter. |
Trop2 Lentivirus |
|||
78710 | BPS Bioscience | 500 µl x 2 | EUR 795 |
Description: The Trop2 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human Trop2 (NM_002353.2) driven by an EF1A promoter and a puromycin selection marker (Figure 1)._x000D_ |
GPC3 Lentivirus |
|||
78711 | BPS Bioscience | 500 µl x 2 | EUR 835 |
Description: The GPC3 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human GPC3 (Glypican 3, NM_ 004484.2) driven by an EF1A promoter and a puromycin selection marker (Figure 1)._x000D_
|
BCMA Lentivirus |
|||
78714 | BPS Bioscience | 500 µl x 2 | EUR 795 |
Description: The BCMA Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human BCMA (NM_ 001192) driven by a CMV promoter and a G418 selection marker (Figure 1)._x000D_ |
FcRL5 Lentivirus |
|||
78715 | BPS Bioscience | 500 µl x 2 | EUR 1005 |
Description: The FcRL5 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human FcRL5 (NM_031281.3) driven by an EF1A promoter and a puromycin selection marker (Figure 1)._x000D_ |
GPRC5D Lentivirus |
|||
78716 | BPS Bioscience | 500 µl x 2 | EUR 795 |
Description: The GPRC5D Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human GPRC5D (NM_018654.1) driven by a CMV promoter and a Hygromycin selection marker (Figure 1)._x000D_ |
NKp46 Lentivirus |
|||
78717 | BPS Bioscience | 500 µl x 2 | EUR 795 |
Description: The NKp46 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human NKp46 (NM_004829.7) driven by an EF1A promoter and a puromycin selection marker (Figure 1)._x000D_ |
EpCAM Lentivirus |
|||
78718 | BPS Bioscience | 500 µl x 2 | EUR 995 |
Description: The EpCAM Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human EpCAM (NM_002354.3) driven by an EF1A promoter and a puromycin selection marker (Figure 1)._x000D_
|
CEACAM5 Lentivirus |
|||
78719 | BPS Bioscience | 500 µl x 2 | EUR 795 |
Description: The CEACAM5 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human CEACAM5 (NM_004363.6) driven by an EF1A promoter and a puromycin selection marker (Figure 1)._x000D_
|
CEACAM6 Lentivirus |
|||
78720 | BPS Bioscience | 500 µl x 2 | EUR 835 |
Description: The CEACAM6 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human CEACAM6 (NM_002483.7) driven by an EF1A promoter and a puromycin selection marker (Figure 1)._x000D_ |
LYPD1 Lentivirus |
|||
78724 | BPS Bioscience | 500 µl x 2 | EUR 795 |
Description: The LYPD1 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human LYPD1 (NM_ 001321234.2) driven by a EF1A promoter and a puromycin selection marker (Figure 1)._x000D_ |
PSMA Lentivirus |
|||
78726 | BPS Bioscience | 500 µl x 2 | EUR 995 |
Description: The PSMA Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human PSMA (NM_ 004476.3) driven by a CMV promoter and a puromycin selection marker (Figure 1)._x000D_
|
FcER1G Lentivirus |
|||
79878 | BPS Bioscience | 500 µl x 2 | EUR 795 |
Description: FcER1G is an adapter protein containing an immunoreceptor tyrosine-based activation motif (ITAM) that transduces activation signals from various immunoreceptors. As a component of the high-affinity immunoglobulin E (IgE) receptor, FcER1G mediates allergic inflammatory signaling in mast cells. FcER1G is also a subunit of other Fc receptors. The FcER1G Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. The particles contain a FcER1G gene (NM_004106.2) driven by an EF1α promoter._x000D_ |
ACE2 Lentivirus |
|||
79944 | BPS Bioscience | 500 µl x 2 | EUR 835 |
Description: Human Angiotensin converting enzyme 2 (ACE2), also known as ACEH, is an integral membrane protein found on the surface of cells in the lungs, arteries, heart, kidney, and intestines. ACE2 serves as the entry point into cells for some coronaviruses, including the two strains that caused outbreaks of Severe acute respiratory syndrome (SARS-CoV) and coronavirus disease 2019 (COVID-19) (SARS-CoV-2)._x000D_ The ACE2 Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain an ACE2 gene (NM_021804.3) driven by an EF1a promoter._x000D_ _x000D_ |
Phospho-GATA4 (Ser262) Blocking Peptide |
|||
AF3316-BP | Affbiotech | 1mg | EUR 234 |
Phospho-GATA4 (Ser105) Blocking Peptide |
|||
AF3317-BP | Affbiotech | 1mg | EUR 234 |
GATA4 DNA-Binding ELISA Kit |
|||
abx596497-96tests | Abbexa | 96 tests | EUR 867.6 |
Monoclonal GATA4 Antibody, Clone: 6H10 |
|||
AMM04714G | Leading Biology | 0.1ml | EUR 633.6 |
Description: A Monoclonal antibody against Human GATA4. The antibodies are raised in Mouse and are from clone 6H10. This antibody is applicable in WB, E |
Polyclonal GATA4 Antibody (aa330-380) |
|||
APR02979G | Leading Biology | 0.05mg | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GATA4 (aa330-380). This antibody is tested and proven to work in the following applications: |
Gata4 ORF Vector (Rat) (pORF) |
|||
ORF067429 | ABM | 1.0 ug DNA | EUR 607.2 |
Anti-GATA4 Rabbit Monoclonal Antibody |
|||
M00499-1 | BosterBio | 100ug/vial | EUR 476.4 |
Description: Rabbit Monoclonal GATA4 Antibody. Validated in IF, WB and tested in Human, Mouse, Rat. |
GATA4 ELISA Kit (Mouse) (OKEH05843) |
|||
OKEH05843 | Aviva Systems Biology | 96 Wells | EUR 794.4 |
Description: Description of target: Transcriptional activator that binds to the consensus sequence 5'-AGATAG-3' and plays a key role in cardiac development. Involved in bone morphogenetic protein (BMP)-mediated induction of cardiac-specific gene expression. Binds to BMP response element (BMPRE) DNA sequences within cardiac activating regions. Acts as a transcriptional activator of ANF in cooperation with NKX2-5.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.09 ng/mL |
GATA4 ELISA Kit (Human) (OKEH05844) |
|||
OKEH05844 | Aviva Systems Biology | 96 Wells | EUR 794.4 |
Description: Description of target: Transcriptional activator that binds to the consensus sequence 5'-AGATAG-3' and plays a key role in cardiac development.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.172 ng/mL |
GATA4 ORF Vector (Human) (pORF) |
|||
ORF020069 | ABM | 1.0 ug DNA | EUR 114 |
Gata4 ORF Vector (Mouse) (pORF) |
|||
ORF045329 | ABM | 1.0 ug DNA | EUR 607.2 |
h GATA4 inducible lentiviral particles |
|||
LVP386 | GenTarget | 1 x107 IFU/ml x 200ul | EUR 541.2 |
Description: Pre-made inducible lentiviral particles for expressing human target: h GATA4 (alternative name: MGC126629), with ORF sequence 100% matching to CDS region in NCBI ID: NM_002052.3. |
Guinea Pig GATA4 ELISA Kit |
|||
EGG0100 | Abclonal | 96Tests | EUR 625.2 |
pECMV-Gata4-m-FLAG Plasmid |
|||
PVT14836 | Lifescience Market | 2 ug | EUR 390 |
QuickTiter Lentivirus Titer Kit (Lentivirus-Associated p24 ELISA) |
|||
VPK-107 | Cell Biolabs | 96 assays | EUR 930 |
Description: Measuring the HIV-1 p24 antigen is a long-established method for lentivirus quantitation. However, the traditional p24 ELISA detects both virus-associated p24 and free p24 generated by 293 cells during transient transfection. Free p24 can account for a substantial portion of total p24 in the supernatant. Therefore, the ELISA typically overestimates the quantity of lentivirus present. Our QuickTiter Lentivirus Titer Kit (Lentivirus-Associated HIV p24) substantially minimizes this problem. A proprietary technology separates the lentivirus from free p24 in solution prior to running the ELISA portion of the assay. |
QuickTiter Lentivirus Titer Kit (Lentivirus-Associated p24 ELISA) |
|||
VPK-107-5 | Cell Biolabs | 5 x 96 assays | EUR 3748.8 |
Description: Measuring the HIV-1 p24 antigen is a long-established method for lentivirus quantitation. However, the traditional p24 ELISA detects both virus-associated p24 and free p24 generated by 293 cells during transient transfection. Free p24 can account for a substantial portion of total p24 in the supernatant. Therefore, the ELISA typically overestimates the quantity of lentivirus present. Our QuickTiter Lentivirus Titer Kit (Lentivirus-Associated HIV p24) substantially minimizes this problem. A proprietary technology separates the lentivirus from free p24 in solution prior to running the ELISA portion of the assay. |
GFP Lentivirus Control |
|||
LTV-300 | Cell Biolabs | 1 vial | EUR 679.2 |
Description: HIV-1 Lentivirus |
RFP Lentivirus Control |
|||
LTV-301 | Cell Biolabs | 1 vial | EUR 679.2 |
Description: HIV-1 Lentivirus |